Cargando…

Adrenal Dysfunction in Mitochondrial Diseases

Cortisol is central to several homeostatic mechanisms including the stress and immune response. Adrenal insufficiency and impaired cortisol production leads to severe, potentially fatal disorders. Several fundamental stages of steroidogenesis occur within the mitochondria. These dynamic organelles n...

Descripción completa

Detalles Bibliográficos
Autores principales: Corkery-Hayward, Madeleine, Metherell, Louise A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862368/
https://www.ncbi.nlm.nih.gov/pubmed/36674647
http://dx.doi.org/10.3390/ijms24021126
_version_ 1784875075191701504
author Corkery-Hayward, Madeleine
Metherell, Louise A.
author_facet Corkery-Hayward, Madeleine
Metherell, Louise A.
author_sort Corkery-Hayward, Madeleine
collection PubMed
description Cortisol is central to several homeostatic mechanisms including the stress and immune response. Adrenal insufficiency and impaired cortisol production leads to severe, potentially fatal disorders. Several fundamental stages of steroidogenesis occur within the mitochondria. These dynamic organelles not only contribute ATP for steroidogenesis, but also detoxify harmful by-products generated during cortisol synthesis (reactive oxygen species). Mutations in nuclear or mitochondrial DNA that impair mitochondrial function lead to debilitating multi-system diseases. Recently, genetic variants that impair mitochondrial function have been identified in people with isolated cortisol insufficiency. This review aimed to clarify the association between mitochondrial diseases and adrenal insufficiency to produce cortisol. Mitochondrial diseases are rare and mitochondrial diseases that feature adrenal insufficiency are even rarer. We identified only 14 cases of adrenal insufficiency in people with confirmed mitochondrial diseases globally. In line with previous reviews, adrenal dysfunction was most prevalent in mitochondrial deletion syndromes (particularly Pearson syndrome and Kearns–Sayre syndrome) and with point mutations that compromised oxidative phosphorylation. Although adrenal insufficiency has been reported with mitochondrial diseases, the incidence reflects that expected in the general population. Thus, it is unlikely that mitochondrial mutations alone are responsible for an insufficiency to produce cortisol. More research is needed into the pathogenesis of adrenal disease in these individuals.
format Online
Article
Text
id pubmed-9862368
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98623682023-01-22 Adrenal Dysfunction in Mitochondrial Diseases Corkery-Hayward, Madeleine Metherell, Louise A. Int J Mol Sci Review Cortisol is central to several homeostatic mechanisms including the stress and immune response. Adrenal insufficiency and impaired cortisol production leads to severe, potentially fatal disorders. Several fundamental stages of steroidogenesis occur within the mitochondria. These dynamic organelles not only contribute ATP for steroidogenesis, but also detoxify harmful by-products generated during cortisol synthesis (reactive oxygen species). Mutations in nuclear or mitochondrial DNA that impair mitochondrial function lead to debilitating multi-system diseases. Recently, genetic variants that impair mitochondrial function have been identified in people with isolated cortisol insufficiency. This review aimed to clarify the association between mitochondrial diseases and adrenal insufficiency to produce cortisol. Mitochondrial diseases are rare and mitochondrial diseases that feature adrenal insufficiency are even rarer. We identified only 14 cases of adrenal insufficiency in people with confirmed mitochondrial diseases globally. In line with previous reviews, adrenal dysfunction was most prevalent in mitochondrial deletion syndromes (particularly Pearson syndrome and Kearns–Sayre syndrome) and with point mutations that compromised oxidative phosphorylation. Although adrenal insufficiency has been reported with mitochondrial diseases, the incidence reflects that expected in the general population. Thus, it is unlikely that mitochondrial mutations alone are responsible for an insufficiency to produce cortisol. More research is needed into the pathogenesis of adrenal disease in these individuals. MDPI 2023-01-06 /pmc/articles/PMC9862368/ /pubmed/36674647 http://dx.doi.org/10.3390/ijms24021126 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Corkery-Hayward, Madeleine
Metherell, Louise A.
Adrenal Dysfunction in Mitochondrial Diseases
title Adrenal Dysfunction in Mitochondrial Diseases
title_full Adrenal Dysfunction in Mitochondrial Diseases
title_fullStr Adrenal Dysfunction in Mitochondrial Diseases
title_full_unstemmed Adrenal Dysfunction in Mitochondrial Diseases
title_short Adrenal Dysfunction in Mitochondrial Diseases
title_sort adrenal dysfunction in mitochondrial diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862368/
https://www.ncbi.nlm.nih.gov/pubmed/36674647
http://dx.doi.org/10.3390/ijms24021126
work_keys_str_mv AT corkeryhaywardmadeleine adrenaldysfunctioninmitochondrialdiseases
AT metherelllouisea adrenaldysfunctioninmitochondrialdiseases